Pfizer CEO points to IRA as a factor that made Seagen an attractive target

[cafead]

via One of the reasons Pfizer sought to purchase Seagen, as part of a $43 billion deal announced this morning, is that the Seattle-based biotech will be able to withstand the coming headwinds of the Inflation Reduction Act and the Medicare price negotiations that come with it.

article source

 

[anonymous]

A wise move.